Croatian health minister arrested in corruption scandal
According to the EPPO's statement, Beros, alongside directors of two hospitals, manipulated public procurement processes from June 2022 to November 2024.
India needs to focus on quality and affordable manufacturing with an increased emphasis on research and innovation if it wants to maintain its stature as the pharmacy of the world, Union Minister of Chemicals and Fertilizers, and Health and Family Welfare Mansukh Mandaviya said on Saturday.
Chairing a roundtable meeting with leading CEOs of the pharmaceutical industry in the country on the second day of the eighth International Conference on Pharma and Medical Device Sector, here, he lauded the growth momentum of the industry. “The industry is progressing at a rapid rate, and to maintain our stature as the ‘Pharmacy of the World’, we need to focus on quality and affordable manufacturing with an increased focus on research and innovation,” he said.
Advertisement
Union Minister of Chemicals and Fertilizers, and Health and Family Welfare Mansukh Mandaviya chaired a roundtable meeting with the leading CEOs of the pharmaceutical industry in the country on the second day of the 8th International Conference on Pharma and Medical Device Sector, here today. S Aparna, Secretary of the Department of Pharmaceuticals, was also present.
Advertisement
Mandaviya urged the stakeholders to capitalise on the current opportunities, stating “Substantial investment in terms of Production Linked Incentive schemes as well as upcoming drug parks are bearing fruitful results. To catalyze growth, we must maintain a degree of competitiveness to consolidate our presence in the world.”
Reiterating the government’s commitment and resolve, the health minister stated “The government is industry-friendly and welcomes opportunities for collaboration. The government and industry, both integral to the nation’s progress, must work cohesively to achieve holistic growth.”
Affirming the government’s support, Mandaviya invited the stakeholders to put forth their suggestions addressing the aspects of pricing, regulatory, policy and strategy, with the respective action points in a detailed presentation and due consideration will be given to facilitate further policy support and growth.
Advertisement
